Norway's regulator for medicines and medical devices. NOMA assesses the cost-effectiveness of medicines, including for Nye metoder, and sets maximum prices.
The Norwegian Medical Products Agency (in Norwegian Direktoratet for medisinske produkter, DMP) describes itself as responsible for ensuring that people and animals have access to safe medicines and medical devices, and for facilitating research and innovation in medical products. Nye metoder's English page, last updated in November 2024, still names it by its earlier name, the Norwegian Medicines Agency (Statens legemiddelverk).
In the Nye metoder system the Agency carries out the assessments of medicines and medical devices, while the Norwegian Institute of Public Health assesses procedures. Its public funding and pricing page says it is responsible for assessing the cost-effectiveness of prescription-only medicines and for setting maximum prices. The coordinates are an approximate Oslo city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/